ORIG3N
Latest round
- Series B
Last raised
- Jul 2018
Total raised
- $28M
Investors
- 13
About ORIG3N
ORIG3N, Inc.Founded in 2014 in Boston, US, ORIG3N, Inc. specializes in providing genetic information and insights to consumers.ORIG3N, Inc. offers a suite of innovative services centered on genetic testing and personal health insights. Their product line includes genetic tests that empower individuals to understand their health risks and optimize their well-being.ORIG3N, Inc. operates on a revenue model that combines subscription services with fees from genetic testing. Clients typically engage through direct purchases and subscription plans, which establish predictable revenue streams. The company aims to roll out new testing solutions targeting personalized health insights by the end of 2020, while also exploring entry into new international markets in Asia and Europe within the next two years.
Who invested in ORIG3N
13 investors across 3 rounds
See all investors in ORIG3N
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ORIG3N
Who invested in ORIG3N?
ORIG3N has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ORIG3N raised?
ORIG3N has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ORIG3N last raise money?
ORIG3N's most recent round on record is a Series B, in Jul 2018.
What does ORIG3N do?
ORIG3N is a biotechnology company.
Where is ORIG3N headquartered?
ORIG3N is headquartered in Boston, US.
Which VCs invest in companies like ORIG3N?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ORIG3N's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ORIG3N? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.